Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
- Monash Univ., Melbourne, VIC (Australia). Monash Inst. of Pharmaceutical Sciences. Drug Discovery Biology. Dept. of Pharmacology
- ConfometRx, Santa Clara, CA (United States)
- Eli Lilly, Indianapolis, IN (United States). Dept. of Neuroscience
- Eli Lilly, Indianapolis, IN (United States). Dept. of Computational Chemistry and Chemoinformatics
- Eli Lilly, Windlesham (United Kingdom). Dept. of Computational Chemistry and Chemoinformatics
- Stanford Univ., CA (United States). School of Medicine. Dept. of Molecular and Cellular Physiology. Dept. of Structural Biology
- ConfometRx, Santa Clara, CA (United States); Stanford Univ., CA (United States). School of Medicine. Dept. of Molecular and Cellular Physiology
Muscarinic M1–M5 acetylcholine receptors are G-protein-coupled receptors that regulate many vital functions of the central and peripheral nervous systems. In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurological disorders, such as Alzheimer’s disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors. In this paper, we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium. Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family. Finally, we also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.
- Research Organization:
- Monash Univ., Melbourne, VIC (Australia); Stanford Univ., CA (United States)
- Sponsoring Organization:
- Lilly Research Award Program (United States); Mathers Foundation (United States); National Health and Medical Research Council (NHMRC) (Australia); National Inst. of Health (NIH) (United States); USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
- Contributing Organization:
- ConfometRx, Santa Clara, CA (United States); Eli Lilly, Indianapolis, IN (United States); Eli Lilly, Windlesham (United Kingdom)
- Grant/Contract Number:
- W-31109-ENG-38
- OSTI ID:
- 1248385
- Journal Information:
- Nature (London), Journal Name: Nature (London) Journal Issue: 7594 Vol. 531; ISSN 0028-0836
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia
Journal Article
·
Wed Feb 29 19:00:00 EST 2012
· Nature
·
OSTI ID:1036023
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Journal Article
·
Wed Mar 14 20:00:00 EDT 2012
· Nature
·
OSTI ID:1035713
Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia
Journal Article
·
Sat Sep 01 00:00:00 EDT 1990
· Proceedings of the National Academy of Sciences of the United States of America; (United States)
·
OSTI ID:5464343